14个住院病人研究发现,Ozempic结合ReCET程序可以消除6个月后对2型糖尿病患者的胰岛素需求。 14-patient study finds Ozempic combined with ReCET procedure may eliminate insulin need for type 2 diabetes patients after six months.

一项小的研究表明,糖尿病药物Ozempic,加上一种称为ReCET的新肠道程序,可以消除2型糖尿病患者对胰岛素的需求。 A small study suggests that the diabetes drug Ozempic, combined with a new intestinal procedure called ReCET, may eliminate the need for insulin in type 2 diabetes patients. 涉及14名参与者的研究发现,有12人六个月后不再需要胰岛素。 Involving 14 participants, the study found that 12 no longer required insulin after six months. 通过ReCET手术, 目标是改善十二指肠的功能. The ReCET procedure targets the duodenum to improve its function. 然而,由于样本规模较小,有必要进一步研究,以确认这些初步结果。 However, due to the small sample size, further research is necessary to confirm these initial results.